Chief Commercial Officer · Vera Therapeutics, Inc. · Class A Common Stock
Side
SELL
Value
$66K
Shares
1,582
Price
$41.98
Executed
Feb 23, 2026
Disclosed
Feb 25, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Feb 23 executedFeb 25, 2026 disclosed
VERA · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering+5 / 15
1 other actor traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Skelton Laurence Matthew filed this Form 4 reporting a open-market sale of VERA on Feb 23, 2026. It became public on Feb 25, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Commercial Officer
Skelton Laurence Matthewcik:0002108080
Issuer
Vera Therapeutics, Inc.cik:0001831828
Revision history · 0
No field has changed since this record was first ingested.
